The Clorox Company (NYSE:CLX) Q2 2023 Earnings Call Transcript

Page 3 of 16

Linda Rendle : Yes. As Kevin just mentioned, we executed that fourth round of pricing in early December. And as Kevin noted, it’s too early to determine, from a consumer perspective, the reaction I would say, to date, everything looks in line with our expectations from an elasticity perspective. But again, too early, we haven’t had a full purchase cycle yet, and it’s still being reflected in the market. As it relates to competition, we did say in this price increase we led for the most part on this round of pricing. And while we’ve seen some category movement in pricing, there are other categories we have not seen competitors move in. yet. And we’re watching that really, really closely to see what that’s going to look like and prepare — we’re prepared to react.

If our price gaps get out of line, or we’re seeing a consumer reaction, not in line with our expectations given the full category hasn’t moved. So too early yet to judge that. But it is true that some categories we have not seen competition move subsequent to our pricing.

Operator: And our next question will come from Andrea Teixeira with JPMorgan.

Andrea Teixeira : So I wanted to go back to the top line outlook improvement. So I think that probably, as you mentioned, is a function of price elasticity or maybe the pull forward of shipments at this point. And is that the reason why you also did not raise guidance as much as you could have given the beat? Is that something that perhaps the retailers took more shipments ahead of the price increase in December? And therefore, you can see some of that pull forward corrected in the third quarter fiscal. Is that how we should be thinking?

Kevin Jacobsen : Andrea, I would say, overall, I feel very good about where we’re at from a top line perspective. And as you saw, we narrowed our range and we moved it to the top half of our range from an organic perspective, we’re now targeting flat to up 3%. If you look at our performance through the first half of the year, organic sales growth is a little over 0.5%. So that success suggests much stronger performance in the back half of the year. And so the outlook, I think, really reflects a good start to the year, but it would project acceleration in the back half of the year in terms of organic sales growth, really driven by, again, good strength in the business plus the ongoing impact of the pricing actions we’re taking.

I think if you look at the range right now, you can do the math, it would suggest the back half would be anywhere from flat to up 5% on an organic basis. And we’ve got still a fairly wide range in the back half of the year. And I think that reflects exactly what Linda was just talking about. There is some uncertainty about how this fourth round of pricing will go. And so we think it’s appropriate to maintain a bit wider range until we see exactly how about the consumers react to this round of pricing as well as what we see from other manufacturers in terms of if they choose to follow or not.

Andrea Teixeira : And with the fourth quarter price increase, just a fine point — I’m sorry, the December price increase, the fourth round, can you remind us again how much would be the average pricing that you’re getting to the beginning of the third quarter, as we enter the third quarter?

Page 3 of 16